Volume 10,Issue 3
Clinical Value of Glibenclamide Combined with Metformin in the Treatment of Diabetes Mellitus in the Elderly
This study investigated the clinical efficacy of glimepiride combined with metformin in elderly diabetic patients. A total of 120 elderly diabetic patients admitted to our hospital between March 2023 and June 2025 were enrolled. Using a randomized block design, the patients were divided into two groups for prospective analysis. The control group received metformin monotherapy, while the observation group received glimepiride combined with metformin. Comparative analyses demonstrated that both groups showed lower fasting blood glucose levels (P<0.05) and lower 2-hour postprandial glucose levels (P>0.05). The combined treatment also showed significantly better glycemic control than metformin monotherapy, with no increased risk of adverse reactions observed. The study concluded that glimepiride combined with metformin effectively managed blood glucose levels in elderly diabetic patients without increasing adverse effects.
[1] Yue C T, 2021, Clinical effect analysis of glibenclamide, glimepiride and acarbose tablets combined for secondary sulfonylurea failure in type 2 diabetes patients. Chinese Prescription Drug, 19(8):120-122.
[2] Chen C, Chen G G, 2021, Clinical study on the efficacy and safety of Gliclazide Sustained-release Tablets and Glimepiride Tablets in the treatment of type 2 diabetes mellitus. New World of Diabetes, 24(3):82-84.
[3] Xiao W H, 2020, The effect of glibenclamide injection combined with glimepiride tablets on the blood glucose control rate in type 2 diabetes patients. Contemporary Medicine, 26(32).98-100.
[4] Liu X, 2020, Effect and safety of glargine insulin injection combined with glibenclamide tablets in the treatment of type 2 diabetes mellitus. Straits Pharmacy, 32(1):174-176.
[5] Chu L M, Jiang X L, 2018, Effects of Compound Pyridoglitazone and Glimepiride Tablets on the Treatment of Type 2 Diabetes Mellitus and Its Effects on Metabolic Levels. Clinical Medical Research and Practice, 3(27): 28-29.34.
[6] Zhang G H, 2018, Efficacy analysis of glibenclamide, glimepiride tablets and acarbose tablets combined with sulfonylurea drugs in treating diabetes mellitus unresponsive to sulfonylurea drugs. Chinese and Foreign Medical Journal, 14(1):120-122.